Exact Mass: 456.198

Delavirdine

C22H28N6O3S (456.1943)

Delavirdine is only found in individuals that have used or taken this drug. It is a potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. [PubChem]Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzymes catalytic site. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

Sudan black B

C29H24N6 (456.2062)

Glochidacuminoside C

C22H32O10 (456.1995)

14-Hydroxyperrottetin E 11-methyl ether

C29H28O5 (456.1937)

Kopsamine

C24H28N2O7 (456.1896)

Bulbocodin D

C29H28O5 (456.1937)

Bulbocodin C

C29H28O5 (456.1937)

Kopsingine

C24H28N2O7 (456.1896)

Singapurensine B

C24H28N2O7 (456.1896)

Benastatin C

C29H28O5 (456.1937)

Perrottetin G

C29H28O5 (456.1937)

2,6-Bis(4-hydroxybenzyl)-3,3-dihydroxy-5-methoxybibenzyl

C29H28O5 (456.1937)

Kopsidasine N-oxide

C24H28N2O7 (456.1896)

13-Me ether,3-O-beta-D-glucopyranoside-3,8,13-Trihydroxy-4(15),10(14)-guaiadien-12,6-olide

C22H32O10 (456.1995)

4-[2-(3-Methoxyphenyl)ethyl]-2-[4-[2-(2,5-dihydroxyphenyl)ethyl]phenoxy]phenol

C29H28O5 (456.1937)

Rengyoside C

C22H32O10 (456.1995)

11a-hydroxy-7,8-dimethoxy-13-methyl-1a,2,3a,4,9c,9d,11,11a-octahydro-5h,10h-9b,11b-(ethanoiminomethano)-1,3-dioxa-5a-azacyclopropa[4,5]cyclohepta[1,2,3-cd]fluoranthene-5,10-dione

C24H28N2O7 (456.1896)

(8E)-decaene-4,6-diyn-1-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside

C22H32O10 (456.1995)

4-deacetyltaxagifine III|4-Decetyltaxagifin III

C22H32O10 (456.1995)

1-(2-hydroxy-3-O-beta-D-cymaropyranosyl-6-O-beta-D-oleandropyranosyl-phenyl)-ethanone

C22H32O10 (456.1995)

jatairidoids C|[(1R,3R,4aR,6S,7R,7aS)-6-(acetyloxy)hexahydro-1,4a-dihydroxy-4-methylidene-3,7-epoxycyclopenta[c]pyran-7(1H)-yl]methyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C22H32O10 (456.1995)

3,7-Dihydroxy Toxin HT2

C22H32O10 (456.1995)

Dichotine, acetate (ester)

C24H28N2O7 (456.1896)

C29H28O5

C29H28O5 (456.1937)

CHEMBL182868

C29H28O5 (456.1937)

Tyr Gln Phe

C23H28N4O6 (456.2009)

Phe Tyr Gln

C23H28N4O6 (456.2009)

Tyr Phe Gln

C23H28N4O6 (456.2009)

Gln Tyr Phe

C23H28N4O6 (456.2009)

ACMC-20mql0

C23H28N4O6 (456.2009)

Ala Glu His Thr

C18H28N6O8 (456.1969)

Ala Glu Thr His

C18H28N6O8 (456.1969)

Ala Phe Gly Tyr

C23H28N4O6 (456.2009)

Ala Phe Tyr Gly

C23H28N4O6 (456.2009)

Ala Gly Phe Tyr

C23H28N4O6 (456.2009)

Ala Gly Tyr Phe

C23H28N4O6 (456.2009)

Ala His Glu Thr

C18H28N6O8 (456.1969)

Ala His Thr Glu

C18H28N6O8 (456.1969)

Ala Thr Glu His

C18H28N6O8 (456.1969)

Ala Thr His Glu

C18H28N6O8 (456.1969)

Ala Tyr Phe Gly

C23H28N4O6 (456.2009)

Ala Tyr Gly Phe

C23H28N4O6 (456.2009)

Asp His Ser Val

C18H28N6O8 (456.1969)

Asp His Val Ser

C18H28N6O8 (456.1969)

Asp Ser His Val

C18H28N6O8 (456.1969)

Asp Ser Val His

C18H28N6O8 (456.1969)

Asp Val His Ser

C18H28N6O8 (456.1969)

Asp Val Ser His

C18H28N6O8 (456.1969)

8-hydroxymianserin glucuronide

C24H28N2O7 (456.1896)

Glu Ala His Thr

C18H28N6O8 (456.1969)

Glu Ala Thr His

C18H28N6O8 (456.1969)

Glu His Ala Thr

C18H28N6O8 (456.1969)

Glu His Thr Ala

C18H28N6O8 (456.1969)

Glu Thr Ala His

C18H28N6O8 (456.1969)

Glu Thr His Ala

C18H28N6O8 (456.1969)

Phe Ala Gly Tyr

C23H28N4O6 (456.2009)

Phe Ala Tyr Gly

C23H28N4O6 (456.2009)

Phe Phe Gly Ser

C23H28N4O6 (456.2009)

Phe Phe Ser Gly

C23H28N4O6 (456.2009)

Phe Gly Ala Tyr

C23H28N4O6 (456.2009)

Phe Gly Phe Ser

C23H28N4O6 (456.2009)

Phe Gly Ser Phe

C23H28N4O6 (456.2009)

Phe Gly Tyr Ala

C23H28N4O6 (456.2009)

Phe Ser Phe Gly

C23H28N4O6 (456.2009)

Phe Ser Gly Phe

C23H28N4O6 (456.2009)

Phe Tyr Ala Gly

C23H28N4O6 (456.2009)

Phe Tyr Gly Ala

C23H28N4O6 (456.2009)

Gly Ala Phe Tyr

C23H28N4O6 (456.2009)

Gly Ala Tyr Phe

C23H28N4O6 (456.2009)

Gly Phe Ala Tyr

C23H28N4O6 (456.2009)

Gly Phe Phe Ser

C23H28N4O6 (456.2009)

Gly Phe Ser Phe

C23H28N4O6 (456.2009)

Gly Phe Tyr Ala

C23H28N4O6 (456.2009)

Gly Ser Phe Phe

C23H28N4O6 (456.2009)

Gly Tyr Ala Phe

C23H28N4O6 (456.2009)

Gly Tyr Phe Ala

C23H28N4O6 (456.2009)

His Ala Glu Thr

C18H28N6O8 (456.1969)

His Ala Thr Glu

C18H28N6O8 (456.1969)

His Asp Ser Val

C18H28N6O8 (456.1969)

His Asp Val Ser

C18H28N6O8 (456.1969)

His Glu Ala Thr

C18H28N6O8 (456.1969)

His Glu Thr Ala

C18H28N6O8 (456.1969)

His Ser Asp Val

C18H28N6O8 (456.1969)

His Ser Val Asp

C18H28N6O8 (456.1969)

His Thr Ala Glu

C18H28N6O8 (456.1969)

His Thr Glu Ala

C18H28N6O8 (456.1969)

His Val Asp Ser

C18H28N6O8 (456.1969)

His Val Ser Asp

C18H28N6O8 (456.1969)

Phe Gln Tyr

C23H28N4O6 (456.2009)

Ser Asp His Val

C18H28N6O8 (456.1969)

Ser Asp Val His

C18H28N6O8 (456.1969)

Ser Phe Phe Gly

C23H28N4O6 (456.2009)

Ser Phe Gly Phe

C23H28N4O6 (456.2009)

Ser Gly Phe Phe

C23H28N4O6 (456.2009)

Ser His Asp Val

C18H28N6O8 (456.1969)

Ser His Val Asp

C18H28N6O8 (456.1969)

Gln Phe Tyr

C23H28N4O6 (456.2009)

Ser Val Asp His

C18H28N6O8 (456.1969)

Ser Val His Asp

C18H28N6O8 (456.1969)

Thr Ala Glu His

C18H28N6O8 (456.1969)

Thr Ala His Glu

C18H28N6O8 (456.1969)

Thr Glu Ala His

C18H28N6O8 (456.1969)

Thr Glu His Ala

C18H28N6O8 (456.1969)

Thr His Ala Glu

C18H28N6O8 (456.1969)

Thr His Glu Ala

C18H28N6O8 (456.1969)

Val Asp His Ser

C18H28N6O8 (456.1969)

Val Asp Ser His

C18H28N6O8 (456.1969)

Val His Asp Ser

C18H28N6O8 (456.1969)

Val His Ser Asp

C18H28N6O8 (456.1969)

Val Ser Asp His

C18H28N6O8 (456.1969)

Val Ser His Asp

C18H28N6O8 (456.1969)

Tyr Ala Phe Gly

C23H28N4O6 (456.2009)

Tyr Ala Gly Phe

C23H28N4O6 (456.2009)

Tyr Phe Ala Gly

C23H28N4O6 (456.2009)

Tyr Phe Gly Ala

C23H28N4O6 (456.2009)

Tyr Gly Ala Phe

C23H28N4O6 (456.2009)

Tyr Gly Phe Ala

C23H28N4O6 (456.2009)

Levocabastine hydrochloride

C26H30ClFN2O2 (456.198)

D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

Boc-Arg(Mts)-OH

C20H32N4O6S (456.2042)

1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol,dihydrochloride

C23H34Cl2N2O3 (456.1946)

Sudan black B

C29H24N6 (456.2062)

D004396 - Coloring Agents

1-[3-(1,3-benzodioxol-5-yloxy)propyl]-4-phenylpiperazine

C24H28N2O7 (456.1896)

ONO-4059 (analog)

C25H24N6O3 (456.191)

Boc-Arg(Mts)-OH·CHA

C20H32N4O6S (456.2042)

3-Quinolineacetic acid, 4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-α-(1,1-dimethylethoxy)-2-methyl-, methyl ester, (αS,4R)-

C28H28N2O4 (456.2049)

Gln-Phe-Tyr

C23H28N4O6 (456.2009)

Tyr-Gln-Phe

C23H28N4O6 (456.2009)

N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)butanediamide

C23H28N4O6 (456.2009)

1-[1-[[1-[(4-Methylphenyl)methyl]-5-tetrazolyl]methyl]-4-piperidinyl]-5-(trifluoromethyl)benzotriazole

C22H23F3N8 (456.1998)

Ethyl 2-[5-benzyloxy-4-(trifluoromethyl)biphenyl-3-yl]pentanoate

C27H27F3O3 (456.1912)

3-(2-((Tributylstannyl)methoxy)phenyl)propan-1-ol

C22H40O2Sn (456.205)

N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]oxane-4-carboxamide

C21H32N2O7S (456.193)

N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide

C21H32N2O7S (456.193)

N-[(2R,4aR,12aR)-2-[2-(ethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-methyl-3-isoxazolecarboxamide

C23H28N4O6 (456.2009)

2-[(3S,6aS,8R,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide

C25H29FN2O5 (456.206)

(3aR,4R,9bS)-8-(4-cyanophenyl)-N-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

C27H25FN4O2 (456.1961)

Gln-Tyr-Phe

C23H28N4O6 (456.2009)

Tyr-Phe-Gln

C23H28N4O6 (456.2009)

Phe-Gln-Tyr

C23H28N4O6 (456.2009)

Phe-Tyr-Gln

C23H28N4O6 (456.2009)

2,6-dimethyl-3,4-dihydropyridine-3,4,5-tricarboxylic acid O4-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl] ester O3,O5-diethyl ester

C24H28N2O7 (456.1896)

CID 168510776

C17H32N2O12 (456.1955)

Delavirdine

C22H28N6O3S (456.1943)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

ST 26:7;O2;S

C26H32O5S (456.197)

P2X3 antagonist 34

C24H26F2N4O3 (456.1973)

P2X3 antagonist 34 is a potent, selective and orally active P2X3 homotrimeric receptor antagonist with IC50s of 25?nM, 92?nM and 126?nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively. P2X3 antagonist 34 is less active against human, rat and guinea pig P2X2/3 heterotrimeric receptors. P2X3 antagonist 34 has strong anti-tussive effect[1].

13,15-dimethyl 15-hydroxy-20-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

C24H28N2O7 (456.1896)

(2r,3r,4s,5s,6r)-2-[(8e)-dec-8-en-4,6-diyn-1-yloxy]-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C22H32O10 (456.1995)

2,18-dimethyl 17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

C24H28N2O7 (456.1896)

(3,4,5-trihydroxy-6-{[2-(4-hydroxycyclohex-1-en-1-yl)acetyl]oxy}oxan-2-yl)methyl 2-(4-hydroxycyclohex-1-en-1-yl)acetate

C22H32O10 (456.1995)

(3r,3ar,4r,6ar,8s,9ar,9br)-4-hydroxy-3-(methoxymethyl)-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

C22H32O10 (456.1995)

2,18-dimethyl (1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate

C24H28N2O7 (456.1896)

2',6'-bis(p-hydroxybenzyl)-3,3'-dihydroxy-5-methoxybibenzyl

C29H28O5 (456.1937)

{"Ingredient_id": "HBIN004864","Ingredient_name": "2',6'-bis(p-hydroxybenzyl)-3,3'-dihydroxy-5-methoxybibenzyl","Alias": "NA","Ingredient_formula": "C29H28O5","Ingredient_Smile": "COC1=CC(=CC(=C1)O)CCC2=C(C=CC(=C2CC3=CC=C(C=C3)O)O)CC4=CC=C(C=C4)O","Ingredient_weight": "456.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2456","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "67233527","DrugBank_id": "NA"}

3′, 3′-dihydroxy- 5-methoxybibenzyl

C29H28O5 (456.1937)

{"Ingredient_id": "HBIN007175","Ingredient_name": "3\u2032, 3\u2032-dihydroxy- 5-methoxybibenzyl","Alias": "NA","Ingredient_formula": "C29H28O5","Ingredient_Smile": "COC1=CC(=CC(=C1)O)CCC2=C(C=CC(=C2CC3=CC=C(C=C3)O)O)CC4=CC=C(C=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

4-deacetyltaxagifine iii

C22H32O10 (456.1995)

{"Ingredient_id": "HBIN010310","Ingredient_name": "4-deacetyltaxagifine iii","Alias": "NA","Ingredient_formula": "C22H32O10","Ingredient_Smile": "CC(=O)OC1CC2C(CO2)(C3C1(C(=O)C(C4(C5(COC4(C(CC5C3O)O)C)C)O)O)C)O","Ingredient_weight": "456.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4777","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101607468","DrugBank_id": "NA"}

3-[2-(4-hydroxy-3-{4-[2-(3-methoxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,2-diol

C29H28O5 (456.1937)

{6-[2-(1,4-dihydroxycyclohexyl)ethoxy]-3,4,5-trihydroxyoxan-2-yl}methyl 2-(4-hydroxyphenyl)acetate

C22H32O10 (456.1995)

13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-15-hydroxy-20-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

C24H28N2O7 (456.1896)

methyl 1-{[(5-{[5-({[2-(methoxycarbonyl)pyrrolidin-1-yl]imino}methyl)furan-2-yl]methyl}furan-2-yl)methylidene]amino}pyrrolidine-2-carboxylate

C23H28N4O6 (456.2009)

5-[2-(3-hydroxyphenyl)ethyl]-2,4-bis[(4-hydroxyphenyl)methyl]-3-methoxyphenol

C29H28O5 (456.1937)

2-[2-(4-{2-hydroxy-5-[2-(3-methoxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,4-diol

C29H28O5 (456.1937)

5-[2-(3-hydroxyphenyl)ethyl]-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}-2-methoxyphenol

C29H28O5 (456.1937)

23-hydroxy-17,18-dimethoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione

C24H28N2O7 (456.1896)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{2-[(1s,4s)-1,4-dihydroxycyclohexyl]ethoxy}oxan-2-yl]methyl 2-(4-hydroxyphenyl)acetate

C22H32O10 (456.1995)

(1s,6r,8r,11r,12r,13s,23s)-23-hydroxy-17,18-dimethoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione

C24H28N2O7 (456.1896)

(1r,2r,3r,5s,6r,9r,10r,11r,13s,14s,19s)-2,5,10,11,19-pentahydroxy-6,9,13-trimethyl-12-oxo-7,17-dioxapentacyclo[11.6.0.0³,⁹.0⁶,¹⁰.0¹⁶,¹⁹]nonadecan-14-yl acetate

C22H32O10 (456.1995)

2,21-dimethyl (1s,12r,19r,21s,24s)-21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.1¹²,¹⁵.0¹,¹².0³,¹¹.0⁴,⁸.0¹⁹,²⁴]tetracosa-3(11),4(8),9-triene-2,21-dicarboxylate

C24H28N2O7 (456.1896)

2-(dec-8-en-4,6-diyn-1-yloxy)-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C22H32O10 (456.1995)

methyl (2s)-1-{[(5-{[5-({[(2s)-2-(methoxycarbonyl)pyrrolidin-1-yl]imino}methyl)furan-2-yl]methyl}furan-2-yl)methylidene]amino}pyrrolidine-2-carboxylate

C23H28N4O6 (456.2009)

2,5,10,11,19-pentahydroxy-6,9,13-trimethyl-12-oxo-7,17-dioxapentacyclo[11.6.0.0³,⁹.0⁶,¹⁰.0¹⁶,¹⁹]nonadecan-14-yl acetate

C22H32O10 (456.1995)

(1r,2r,3r,5s,6r,9r,10r,11r,13s,14s,16r,19s)-2,5,10,11,19-pentahydroxy-6,9,13-trimethyl-12-oxo-7,17-dioxapentacyclo[11.6.0.0³,⁹.0⁶,¹⁰.0¹⁶,¹⁹]nonadecan-14-yl acetate

C22H32O10 (456.1995)

2,21-dimethyl (12r,21s,24s)-21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.1¹²,¹⁵.0¹,¹².0³,¹¹.0⁴,⁸.0¹⁹,²⁴]tetracosa-3(11),4(8),9-triene-2,21-dicarboxylate

C24H28N2O7 (456.1896)

4-hydroxy-3-(methoxymethyl)-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one

C22H32O10 (456.1995)

3-[2-(3-hydroxyphenyl)ethyl]-2,6-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol

C29H28O5 (456.1937)

5,13,17,19-tetrahydroxy-22,22-dimethyl-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4(9),5,7,10,13,16,18,20-decaen-15-one

C29H28O5 (456.1937)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-({2-[(4s)-4-hydroxycyclohex-1-en-1-yl]acetyl}oxy)oxan-2-yl]methyl 2-[(4s)-4-hydroxycyclohex-1-en-1-yl]acetate

C22H32O10 (456.1995)

3-[2-(3-hydroxyphenyl)ethyl]-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol

C29H28O5 (456.1937)